ZO FUTURE GROUP(02309)
Search documents
大象未来集团(02309)拟出售BCL约51.72%股权以聚焦新能源汽车及相关业务
Xin Lang Cai Jing· 2025-11-07 14:36
Group 1 - The company has entered into a share purchase agreement to sell approximately 51.72% of BCL's issued share capital and rights to a shareholder loan of about £19.2 million for a total consideration of approximately £5 million, expected to generate around HKD 246.2 million in pre-tax profit [1] - BCL primarily engages in the operation and management of BCFC, a wholly-owned subsidiary that operates a professional football club in the UK [1] - The sale is seen as an opportunity for the company to liquidate its investment in the BCL group and to consolidate financial resources, allowing it to focus on growth opportunities in the new energy vehicle sector and related businesses [1]
大象未来集团拟出售BCL约51.72%股权以聚焦新能源汽车及相关业务
Zhi Tong Cai Jing· 2025-11-07 14:31
Core Viewpoint - The company has entered into a share purchase agreement to sell approximately 51.72% of BCL's issued share capital and rights to a shareholder loan of about £19.2 million for a total consideration of approximately £5 million, which is expected to generate a pre-tax profit of about HKD 246.2 million [1] Group 1 - The transaction involves the sale of BCL, which primarily operates and manages BCFC, a wholly-owned subsidiary engaged in running a professional football club in the UK [1] - The sale is expected to relieve the company from further financial support obligations to the BCL group and provide an opportunity to monetize its investment in BCL [1] - The company aims to consolidate financial resources and focus on growth opportunities in the new energy vehicle and related businesses [1]
大象未来集团(02309) - 主要及关连交易有关出售一间非全资附属公司
2025-11-07 14:19
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 ZO FUTURE GROUP 大 象 未 來 集 團 (於開曼群島註冊成立之有限公司) (股份代號:2309) 主要及關連交易 有關出售一間非全資附屬公司 出售事項 於2025年11月7日(交易時段後),本公司、BCL與SCL訂立股份購買協議,據此, 本公司已同意出售及SCL已同意購買BCL之已發行股本約51.72%,以及BCL結欠 本公司總額約為19,200,000英鎊(相等於約205,800,000港元)之股東貸款之權利、 擁有權、權益及利益,總代價約為5,000,000英鎊(相等於約53,500,000港元)。 1 由於概無股東須於本公司倘若就批准股份購買協議及其項下擬進行之交易召開 的 股 東 特 別 大 會 上 放 棄 投 票,且 本 公 司 已 取 得 密 切 聯 繫 成 員(合 共 持 有 490,307,652股股份,佔本公告日期已發行股份總數約53.14%)就股份購買協議 及其項下擬 ...
大象未来集团(02309) - 截至2025年10月31日止之股份发行人的证券变动月报表
2025-11-04 10:19
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02309 | 說明 | 不適用 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.25 HKD | | 500,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.25 HKD | | 500,000,000 | 本月底法定/註冊股本總額: HKD 500,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 | | | 致:香港交易及結算所有限公司 公司名稱: 大象未來集團 呈交日期: 2025年11 ...
大象未来集团(02309) - 致非登记股东的通知信函及申请表格
2025-10-27 10:07
ZO FUTURE GROUP 大 象 未 來 集 團 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號: 2309) NOTIFICATION LETTER 通知信函 Dear Non-registered Shareholder(s) (Note 1) , 28 October 2025 ZO Future Group (the "Company") – Notice of publication of Annual Report for the year ended 30 June 2025 (the "Current Corporate Communication") and 2024/2025 Environmental, Social and Governance Report ("ESG Report") The English and Chinese versions of the Company's Current Corporate Communicat ...
大象未来集团(02309) - 致登记股东的通知信函及回条
2025-10-27 10:06
ZO FUTURE GROUP 大 象 未 來 集 團 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號: 2309) NOTIFICATION LETTER 通知信函 The English and Chinese versions of the Company's Current Corporate Communication are now available on the Company's website at www.zogroup.com.hk and the website of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") at www.hkexnews.hk (the "Website Version"). The Company strongly recommends you to access the Website Version of the Current Corp ...
大象未来集团(02309) - 环境、社会及管治报告2024/2025
2025-10-27 10:04
ZO FUTURE GROUP 大象未來集團 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號 : 2309) ENVIRONMENTAL, SOICAL AND GOVERNANCE REPORT 2024/2025 環境、社會及管治報告 31/F., Vertical Sq, No. 28 Heung Yip Road, Wong Chuk Hang, Hong Kong 香港黃竹坑香葉道28號嘉尚匯31樓 Tel 電話: (852) 2548 2928 Fax 傳真: (852) 2548 2782 Website 網頁: www.zogroup.com.hk ZO FUTURE GROUP 大象未來集團 CONTENTS 目錄 | ABOUT THIS REPORT | 有關本報告 | 2 | | --- | --- | --- | | GOVERNANCE STRUCTURE | 管治架構 | 2 | | REPORTING PRINCIPLES | 報告原則 | ...
大象未来集团(02309) - 2025 - 年度财报
2025-10-27 10:02
Financial Performance - For the year ended June 30, 2025, the Group's revenue was approximately HK$451.2 million, representing an increase of approximately 63.9% compared to HK$275.2 million for the year ended June 30, 2024[32][35]. - The Group recorded a loss attributable to owners of approximately HK$314.0 million for the year ended June 30, 2025, an increase of approximately 71.8% from the loss of approximately HK$182.8 million for the year ended June 30, 2024[33][36]. - The basic loss per share for the year ended June 30, 2025, was approximately HK38.04 cents, compared to approximately HK23.37 cents for the previous year[34][37]. - Operating expenses for the year were approximately HK$825.2 million, reflecting an increase of approximately 44.6% from HK$570.6 million in 2024[55][59]. - Finance costs increased to approximately HK$116.1 million, representing a rise of approximately 215.3% compared to HK$36.8 million in 2024[72]. - The Group recorded other gains, net of approximately HK$33.7 million, compared to other losses of approximately HK$54.1 million in 2024[57][61]. - The Group's total borrowings as of June 30, 2025, were approximately HK$1,072.0 million, compared to approximately HK$532.8 million in 2024, with a significant portion repayable after two years[87]. - The current ratio decreased to approximately 75.9% in 2025 from 129.5% in 2024, while the gearing ratio increased to approximately 74.7% from 53.8%[86]. - The Group's bank balances and cash as of June 30, 2025, were approximately HK$242.4 million, up from approximately HK$145.3 million in 2024[87]. - The Group's net current liabilities and net liabilities were approximately HK$188.7 million and HK$89.6 million, respectively, as of June 30, 2025[93]. - The Group's total liabilities to total assets ratio was approximately 104.5% in 2025, compared to 83.6% in 2024[86]. Electric Vehicles and Sustainability - The Group is focused on addressing climate change and meeting "zero carbon" or "carbon neutrality" targets through the promotion of electric commercial vehicles[15]. - The penetration rate of electric commercial vehicles is rapidly increasing, with successful deployment in various scenarios such as mining, ports, and urban freight[16]. - The transition from fuel-powered to electric commercial vehicles represents a disruptive replacement of a multi-trillion-dollar existing market[16]. - Advancements in battery and charging technologies, along with improved infrastructure, are expected to enhance the advantages of electric commercial vehicles[16]. - The shift to electric vehicles will create a new industrial chain ecosystem, including complete vehicles, battery spare parts, and charging infrastructure[16]. - The Group aims to provide innovative electric mobility solutions to contribute to global environmental protection and greenhouse gas emission control[26]. - The electric commercial vehicle market is projected to disrupt a multi-trillion dollar existing market, with a focus on replacing traditional fuel vehicles in logistics[19]. - The Group aims to enhance brand influence and expand its product portfolio in the new energy automobiles sector while building a green energy ecosystem for electric vehicles[45][49]. Market Expansion and Investments - The Group plans to expand into Southeast Asian markets, including Singapore, Malaysia, Thailand, and Vietnam, to enhance its market presence[20]. - The Group has invested in several residential and commercial properties in Phnom Penh, Cambodia, providing a stable income stream despite a challenging investment environment[24]. - The management remains optimistic about Cambodia's economic prospects and aims for steady growth in property investments[24]. Football Club Performance - The football club segment recorded a loss of approximately HK$409 million, representing a year-on-year increase of approximately 44.4%[21]. - The football club segment generated revenue of approximately HK$299.3 million, a year-on-year increase of approximately 24.9%, but recorded a segment loss of approximately HK$409.0 million, up approximately 44.4%[39][43]. - The football club is set to compete in the EFL Championship for the 2025/26 season after being promoted from EFL League One[39]. Management and Governance - The management team emphasizes strategic flexibility and commitment to core missions to navigate market cycles and seize opportunities[26]. - The company has a diverse board with members possessing expertise in various sectors, including finance, education, and corporate governance[141][144][145][147][152]. - The board includes independent non-executive directors who contribute to the company's governance and strategic oversight[145][147][152]. - The company emphasizes the importance of corporate governance and strategic development through its experienced leadership team[138][144][145]. - The leadership team is well-equipped to navigate market challenges and drive the company's growth strategy[138][144][145][152]. Financial Risks and Challenges - The Group's financial condition may be influenced by fluctuations in the global economy and specific market conditions, posing business risks[115]. - The Group is exposed to financial risks including interest rate, foreign currency, credit, and liquidity risks in its ordinary course of business[116]. - The Group acknowledges the potential adverse effects of international political risks on trade and economic activities, which could impact its business operations[122]. - The Group's financial performance may be affected by global economic conditions and market instability, highlighting the importance of monitoring economic trends[119]. Compliance and Regulations - The Group has complied with all relevant laws and regulations during the year ended June 30, 2025, with no material breaches reported[123]. - The Group is committed to environmental sustainability and complies with local environmental protection laws and regulations[129]. - The Group actively monitors cash flows to ensure sufficient liquidity to meet operational needs and commitments, reducing liquidity risk[121]. Shareholder Information - The Board does not recommend the payment of a final dividend for the year ended June 30, 2025, consistent with the previous year[159][165]. - As of June 30, 2025, the Company's distributable reserves amounted to approximately HK$135,749,000, an increase from approximately HK$123,451,000 in 2024[170][176]. - The Company operates in sectors including a professional football club in the UK, new energy automobiles, and property investment in Cambodia[157][164].
大象未来集团(02309) - 截至2025年9月30日止之股份发行人的证券变动月报表
2025-10-02 08:55
上月底結存 2,000,000,000 HKD 0.25 HKD 500,000,000 增加 / 減少 (-) 0 HKD 0 本月底結存 2,000,000,000 HKD 0.25 HKD 500,000,000 本月底法定/註冊股本總額: HKD 500,000,000 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致:香港交易及結算所有限公司 | | | | | | | 公司名稱: | 大象未來集團 | | | | | | 呈交日期: | 2025年10月2日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02309 | 說明 | 不適用 | | | 第 1 頁 共 10 頁 v 1.1.1 FF301 法定/註冊股份數目 面值 法定/註冊股 ...
港股公告掘金 | 来凯医药-B:I期临床MAD研究取得积极初步结果 LAE102展现出令人鼓舞的增肌减脂趋势
Zhi Tong Cai Jing· 2025-09-29 15:29
Major Events - Lai Kai Pharmaceutical-B (02105) reported positive preliminary results from Phase I clinical MAD study, with LAE102 showing encouraging trends in muscle gain and fat loss [1] - Fuhong Hanlin (02696) received FDA approval for the Phase I clinical trial application of HLX13 for first-line treatment of unresectable hepatocellular carcinoma (HCC) patients [1] - Ningmeng Media (09857) has commenced filming the urban medical emotional drama "Asking Heart 2" [1] - CRRC Corporation (01766) and its subsidiaries signed significant contracts totaling approximately 54.34 billion [1] - Heng Rui Pharmaceutical (01276) received approval to conduct clinical trials for SHR-7787 injection, SHR-4849 injection, Bevacizumab injection, and Atezolizumab injection [1] - Hema Medical (03309) entered into a tripartite global licensing and collaboration agreement with Gilead and Hanmi regarding enecuidar [1] - Jinfang Pharmaceutical-B (02595) completed the enrollment of the first patient in the Phase I/II clinical trial of the molecular glue Pan RAS(ON) inhibitor GFH276 for RAS mutant cancer patients [1] - Gao Shi Medical (02407) obtained international certification for its medical device quality management system [1] Operating Performance - Shenzhen Expressway Company (00548) reported toll revenue of 114 million for the Outer Ring project in August [1] - China National Automobile (00026) announced an annual performance with a post-tax loss attributable to shareholders of 185 million HKD, a year-on-year reduction of 29.64% [1] - OKURA HOLDINGS (01655) reported an annual profit attributable to shareholders of 1.342 billion JPY, a year-on-year decrease of 34.34% [1] - Elephant Future Group (02309) disclosed an annual performance with a loss attributable to owners of approximately 314 million HKD, a year-on-year increase of 71.77% [1] - Henghe Group (00513) reported an annual performance with a loss attributable to owners of approximately 259 million HKD, a year-on-year increase of 0.7% [1]